| P50 | author | Hal B Jenson | Q58885975 |
| | Mardge H. Cohen | Q112651887 |
| P2093 | author name string | Jiri Mestecky | |
| | Sharon M Wahl | |
| | Wendy Mack | |
| | Andrea Kovacs | |
| | Edward N Janoff | |
| | Patricia Reichelderfer | |
| | Mahvash Navazesh | |
| | Shawna Christensen | |
| | Maryann Redford | |
| | DATRI 009 Study Group | |
| | Jon Cohn | |
| P2860 | cites work | Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia | Q24541451 |
| | Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection | Q27485184 |
| | The role of the oral environment in HIV-1 transmission | Q28278090 |
| | Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 |
| | Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants | Q33609816 |
| | Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity | Q33780434 |
| | The mouth: a gateway or a trap for HIV? | Q33874252 |
| | Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study | Q33973786 |
| | Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations | Q34055986 |
| | Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor | Q34180810 |
| | Oral manifestations of sexually transmitted diseases | Q34375981 |
| | Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis | Q34804928 |
| | Genital herpes and human immunodeficiency virus: double trouble | Q35882385 |
| | Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics | Q35892927 |
| | Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk | Q36055396 |
| | Immunologic uniqueness of the genital tract: challenge for vaccine development | Q36099546 |
| | Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva | Q36381031 |
| | HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy | Q36401419 |
| | HIV accomplices and adversaries in macrophage infection | Q36565458 |
| | Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism | Q36898823 |
| | Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans | Q36971813 |
| | Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons | Q37116400 |
| | Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease | Q37189179 |
| | Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda | Q38881073 |
| | Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells | Q38945636 |
| | Modulation of Human Immunodeficiency Virus Type 1 Infection of Human Monocytes by IgA | Q39101022 |
| | Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen | Q39448554 |
| | Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. | Q39933471 |
| | Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression | Q40841586 |
| | Do we still need a cohort study of women with HIV infection? | Q40866620 |
| | Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients | Q40878140 |
| | Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation | Q40957208 |
| | Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women | Q41609539 |
| | Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor | Q44019495 |
| | Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. | Q44899910 |
| | Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission | Q45738773 |
| | Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. | Q45754911 |
| | Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription | Q45761404 |
| | Determinants of HIV-1 shedding in the genital tract of women. | Q45963461 |
| | Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. | Q46026052 |
| | Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection | Q46180015 |
| | HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers | Q46690098 |
| | Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. | Q54559569 |
| | Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects | Q57997566 |
| | Clinical and epidemiologic features of primary HIV infection | Q71182378 |
| | Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group | Q77707898 |
| | Structural basis of the gp120 superantigen-binding site on human immunoglobulins | Q77716038 |
| | The macrophage origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids | Q77882766 |
| | HIV and herpes co-infection, an unfortunate partnership | Q79892752 |
| | Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals | Q81109508 |
| | The Women's Interagency HIV Study. WIHS Collaborative Study Group | Q95805016 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 401-411 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Systemic and mucosal differences in HIV burden, immune, and therapeutic responses | |
| P478 | volume | 56 | |